Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 42.1% in November

Aethlon Medical, Inc. (NASDAQ:AEMD) saw a significant decrease in short interest during the month of November. As of November 30th, there was short interest totalling 203,400 shares, a decrease of 42.1% from the November 15th total of 351,100 shares. Based on an average daily trading volume, of 615,200 shares, the short-interest ratio is currently 0.3 days.

Aethlon Medical Stock Performance

AEMD opened at $0.37 on Friday. The stock has a 50-day moving average of $0.39 and a 200 day moving average of $0.42. Aethlon Medical has a 12 month low of $0.24 and a 12 month high of $2.35. The firm has a market cap of $5.11 million, a P/E ratio of -0.13 and a beta of 1.79.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. StockNews.com started coverage on Aethlon Medical in a research note on Tuesday. They issued a “sell” rating on the stock. HC Wainwright restated a “buy” rating and issued a $7.00 price target on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.